Hayes Christopher G.
SEC CIK 1805359 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | CLO | 176.5K | $37.5K | $511.8K | 11 | 2022-07-05 | 2025-03-17 |
Most active insiders at VRCA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Manning Paul B | Dir, 10% | $17.49M | — |
| 2 | Rieger Jayson | CEO, Pres, Dir | $525.6K | — |
| 3 | Zawitz David | COO | $72.3K | — |
| 4 | Rosenberg Noah L. | CMO | $40.6K | — |
| 5 | Kirby John J. | Interim CFO | $39.6K | — |
Hayes Christopher G. made no open-market trades at VRCA in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-17 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | S - Sale | $0.65 | -4,315 | 176.5K | -2% | -$2,805 |
| A | 2025-02-06 | 2023-08-24 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | A - Grant | $0.00 | +150.0K | 231.9K | +183% | $0 |
| M | 2024-08-28 | 2024-08-26+ | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | S - Sale | $2.61 | -35.7K | 105.8K | -25% | -$93.1K |
| M | 2024-07-23 | 2024-07-22+ | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | S - Sale | $7.06 | -21.7K | 141.6K | -13% | -$153.5K |
| D | 2024-03-19 | 2024-03-15 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | A - Grant | $0.00 | +40.0K | 163.2K | +32% | $0 |
| M | 2023-11-16 | 2023-11-14+ | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | S - Sale | $2.94 | -33.7K | 123.2K | -21% | -$99.2K |
| 2023-08-28 | 2023-08-24 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | A - Grant | $0.00 | +75.0K | 156.9K | +92% | $0 | |
| 2023-07-25 | 2023-07-21 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | A - Grant | $0.00 | +100.0K | 115.7K | +636% | $0 | |
| 2023-07-25 | 2023-07-24 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | S - Sale | $4.83 | -33.8K | 81.9K | -29% | -$163.2K | |
| 2022-07-11 | 2022-07-11 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | P - Purchase | $3.40 | +7,500 | 15.7K | +91% | +$25.5K | |
| 2022-07-05 | 2022-07-05 | VRCA | Verrica Pharmaceuticals Inc. | Hayes Christopher G. | CLO | P - Purchase | $2.10 | +5,714 | 8,214 | +229% | +$12.0K |
Purchase Sale Sale after option exercise All abbreviations